Your browser doesn't support javascript.
loading
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).
Rutkowski, Piotr; Jagielska, Beata; Andrzejuk, Jolanta; Bylina, Elzbieta; Lugowska, Iwona; Switaj, Tomasz; Kosela-Paterczyk, Hanna; Kozak, Katarzyna; Falkowski, Slawomir; Klimczak, Anna.
Afiliação
  • Rutkowski P; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Jagielska B; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Andrzejuk J; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Bylina E; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Lugowska I; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Switaj T; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Kosela-Paterczyk H; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Kozak K; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Falkowski S; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Klimczak A; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Contemp Oncol (Pozn) ; 21(4): 285-289, 2017.
Article em En | MEDLINE | ID: mdl-29416434
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article